600211.SHG Tibet Rhodiola Pharmaceutical Holding Co

Healthcare Health Care Providers & Services Shanghai Stock Exchange
40.70 CNY
Close of Nov 4, 2026
34.80 48.99
Market cap
CNY 13.1B
P/E
12.8x
P/B
3.40x
ROE
27.9%
Dividend yield
4.71%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600211.SHG undervalued?

Graham number
Price40.70
Graham value29.29
Premium39.0%

600211.SHG trades 39.0% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Tibet Rhodiola Pharmaceutical Holding Co fundamental analysis

No fundamental analysis for Tibet Rhodiola Pharmaceutical Holding Co yet.

Tibet Rhodiola Pharmaceutical Holding Co stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Tibet Rhodiola Pharmaceutical Holding Co

Tibet Rhodiola Pharmaceutical Holding Co. produces and sells pharmaceutical products in China and internationally. The company offers modern Tibetan Medicines, including Nodikang capsules and granules, snow mountain golden arhat pain relief film, and ten-flavor Tida capsules; modern Chinese medicines, such as children Shuangqing granules, lipid clearing capsules, ginseng and zhi capsules, puyu capsules, and epilepsy flat film; and recombinant human brain natriuretic peptide …

Full company profile